Margin evaluation with fluorescence confocal microscopy during minimally invasive radical prostatectomy
BJU International · 2026-06 · 138 (S1)
DOI: 10.1111/bju.70264 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, online erschienen am 31.03.2026. Verfasst von Josep M Gaya und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fundació Puigvert, Barcelona, Spain. Hauptthemen laut MEDLINE: Prostatectomy, Prostatic Neoplasms, Margins of Excision. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objectives
To demonstrate the reliability and diagnostic accuracy of fluorescence confocal microscopy (FCM) analysis of surgical margins during minimally invasive radical prostatectomy (RP). Patients and Methods From January 2022 to February 2023, we enrolled 100 consecutive patients in this single‐centre, prospective, non‐randomised trial (C2021/32). The VivaScope® 2500M‐G4 microscope (Mavig GmbH, Munich, Germany), a laser scanning microscope designed for rapid acquisition of high‐resolution digital images, was employed. Following surgery, each posterolateral prostatic margin was analysed using FCM and reviewed by two expert urological pathologists. This study aimed to assess the accuracy of FCM in evaluating surgical margins during RP, comparing the diagnostic accuracy of FCM to final anatomical pathology (AP) and assessing the inter‐rater agreement between two urological pathologists (Cohen's kappa agreement).
Results
A total of 100 patients (i.e., 200 surgical margins) were included. Overall, 37 margins in 33 patients were positive according to FCM. At final pathology, 38 specimens in 29 patients were positive. On a per‐patient analysis sensitivity, specificity, positive predictive value, and negative predictive value of FCM were 65.5%, 80.2%, 57.5%, and 85.0%, respectively. On a per‐margin analysis, they were 60.5%, 91.3%, 62.1%, and 90.7%, respectively. The inter‐rater agreement was 0.64 and 0.61 for per‐patient and per‐margin analysis, respectively.
Conclusions
Fluorescence confocal microscopy is a feasible technology to be employed during RP, offering a good diagnostic accuracy without distorting final AP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Fundació Puigvert, Barcelona, Spain.
- Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
- Department of Surgery, Autonomous University of Barcelona, Bellaterra, Spain.
- Department of Urology, IRCCS Humanitas Research Hospital, Milan, Italy.
- Department of Urology, North Hospital, Aix-Marseille University, APHM, Marseille, France.
- Department of Urology, The Royal Free London NHS Foundation Trust, London, UK.
ORCID-Profile: Paolo Verri, Andrea Gallioli, Alessandro Uleri, Giuseppe Basile, Luca Afferi, Pietro Diana, Michael Baboudjian, Francesco Sanguedolce
Zitieren
APA
Gaya, J. M., Verri, P., Gallioli, A., Uleri, A., Basile, G., Afferi, L., Diana, P., Baboudjian, M., Territo, A., Sanguedolce, F., Huguet, J., Arce, Y., Algaba, F., Palou, J., & Breda, A. (2026). Margin evaluation with fluorescence confocal microscopy during minimally invasive radical prostatectomy. BJU International, 138(S1). https://doi.org/10.1111/bju.70264
Vancouver
Gaya JM, Verri P, Gallioli A, Uleri A, Basile G, Afferi L, et al. Margin evaluation with fluorescence confocal microscopy during minimally invasive radical prostatectomy. BJU International. 2026;138(S1). doi:10.1111/bju.70264
BibTeX
@article{Gaya2026,
author = {Gaya, Josep M and Verri, Paolo and Gallioli, Andrea and Uleri, Alessandro and Basile, Giuseppe and Afferi, Luca and Diana, Pietro and Baboudjian, Michael and Territo, Angelo and Sanguedolce, Francesco and Huguet, Jordi and Arce, Yolanda and Algaba, Ferran and Palou, Joan and Breda, Alberto},
title = {Margin evaluation with fluorescence confocal microscopy during minimally invasive radical prostatectomy},
journal = {BJU International},
year = {2026},
volume = {138},
number = {S1},
doi = {10.1111/bju.70264}
}
EUVIMED